Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06495190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cognition, Flavonoids, Exercise, Gut Microbiome

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Start date changed from estimate of Nov 1, 2024 to Jan 1, 2025
    • Secondary endpoints: 3 to 4
    • Study description expanded, about 348 words
    • Site details revised
  2. Notable Start date: Aug 1, 2024 to Nov 1, 2024
    • Eligibility criteria expanded, about 18 words
    • Study description expanded, about 1 word
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This NIH project will examine the effects of routine flavonoid-rich blueberry intake (12-weeks), combined with or in the absence of regular moderate exercise, on cognitive function in a clinical population of older participants identified as experiencing age-related cognitive changes. This project's hypothesis is that the combination of flavonoid-rich diet and routine physical activity may potentiate cognitive benefits and reduce cognitive decline in an aging population, via mechanisms mediated by the gut microbiome.
Trial Details
NCT Number NCT06495190
Lead Sponsor Appalachian State University
Conditions
(from sponsor)
Cognitive Decline, Mild
Related terms Cognitive Dysfunction, Lymphoma, Follicular, Motor Activity
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov